UFP Technologies (UFP Technologies) ROCE % : 14.68% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is UFP Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. UFP Technologies's annualized ROCE % for the quarter that ended in Dec. 2023 was 14.68%.

UFP Technologies ROCE % Historical Data

The historical data trend for UFP Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UFP Technologies ROCE % Chart

UFP Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

14.27

9.09

8.79

17.97

17.23

UFP Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															13.04	15.45	19.97	17.52	14.68

UFP Technologies ROCE % Calculation

UFP Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	57.547	/	( ( (378.192 - 55.961)	+	(404.136 - 58.209) )	/ 2 )
	=	57.547	/	( (322.231	+	345.927)	/ 2 )
	=	57.547	/	334.079
	=	17.23 %

UFP Technologies's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	50.588	/	( ( (399.81 - 56.588)	+	(404.136 - 58.209) )	/ 2 )
	=	50.588	/	( ( 343.222	+	345.927 )	/ 2 )
	=	50.588	/	344.5745
	=	14.68 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

UFP Technologies (NAS:UFPT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

UFP Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of UFP Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

UFP Technologies (UFP Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UFP Technologies Inc (NAS:UFPT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

UFP:Germany

Address

100 Hale Street, Newburyport, MA, USA, 01950-3504

Website

https://www.ufpt.com

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing highly specialized foams, films, and plastics primarily for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Executives

R Jeffrey Bailly	director, 10 percent owner, officer: President and CEO	100 HALE STREET, NEWBURYPORT MA 01950
Mitchell Rock	officer: Vice President	C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833
Jason Holt	officer: Vice President	100 HALE STREET, NEWBURYPORT MA 01950
Symeria Hudson	director	100 HALE STREET, NEWBURYPORT MA 01950
Joseph Hassett	director	ONE TECHNOLOGY WAY, NORWOOD MA 02062
Daniel C Croteau	director	C/O LYNCH, BREWER, HOFFMAN & FINK, LLP, 75 FEDERAL STREET, 7TH FLOOR, BOSTON MA 02110
Cynthia L Feldmann	director	17 WINTHROP ROAD, WAYLAND MA 01778
Christopher P. Litterio	officer: Senior Vice President	C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT MA 02143
Ronald J Lataille	officer: Chief Financial Officer
Thomas Oberdorf	director	C/O GETTY IMAGES, INC., 601 N 34TH ST, SEATTLE WA 98103
Marc D Kozin	director
Steve Cardin	officer: Vice President	100 HALE STREET, NEWBURYPORT MA 01950
Daniel J Shaw	officer: Vice President
W David Smith	officer: Vice President	172 EAST MAIN STREET, GEORGETOWN MA 01833
Pierce Robert W Jr	director	C/O UFP TECHNOLOGIES, INC., 172 EAST MAIN STREET, GEORGETOWN MA 01833